Pooled analysis of clinical outcome for EGFR TKI-treated patients with EGFR mutation-positive NSCLC

por Paz-Ares, Luis, Soulières, Denis, Moecks, Joachim, Bara, Ilze, Mok, Tony, Klughammer, Barbara
Publicado 2014

Association of Immune-Related Adverse Events With Efficacy of Atezolizumab in Patients With Non–Small Cell Lung Cancer: Pooled Analyses of the Phase 3 IMpower130, IMpower132, and I...

por Socinski, Mark A., Jotte, Robert M., Cappuzzo, Federico, Nishio, Makoto, Mok, Tony S. K., Reck, Martin, Finley, Gene G., Kaul, Monika D., Yu, Wei, Paranthaman, Nindhana, Bāra, Ilze, West, Howard J.
Publicado 2023

Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

por Negrao, Marcelo V, Skoulidis, Ferdinandos, Montesion, Meagan, Schulze, Katja, Bara, Ilze, Shen, Vincent, Xu, Hao, Hu, Sylvia, Sui, Dawen, Elamin, Yasir Y, Le, Xiuning, Goldberg, Michael E, Murugesan, Karthikeyan, Wu, Chang-Jiun, Zhang, Jianhua, Barreto, David S, Robichaux, Jacqulyne P, Reuben, Alexandre, Cascone, Tina, Gay, Carl M, Mitchell, Kyle G, Hong, Lingzhi, Rinsurongkawong, Waree, Roth, Jack A, Swisher, Stephen G, Lee, Jack, Tsao, Anne, Papadimitrakopoulou, Vassiliki, Gibbons, Don L, Glisson, Bonnie S, Singal, Gaurav, Miller, Vincent A, Alexander, Brian, Frampton, Garrett, Albacker, Lee A, Shames, David, Zhang, Jianjun, Heymach, John V
Publicado 2021